Hanna Blaney,Amon Asgharpour
Hanna Blaney
Purpose of review: Alcohol-associated hepatitis is a severe form of alcohol-associated liver disease and is associated with a high mortality. Treatment of alcohol-associated hepatitis has historically been limited, with f...
Small-bowel capsule endoscopy - from clinic to couch: time to go green? [0.03%]
胶囊内镜从小病房到大诊所：是时候绿色行动了吗？
Ian Io Lei,Ramesh P Arasaradnam,Anastasios Koulaouzidis
Ian Io Lei
Purpose of review: Small-bowel capsule endoscopy (SBCE) has transformed small-intestine diagnostics by enabling direct, noninvasive mucosal visualization. As healthcare systems increasingly prioritize value-based and sust...
Cristina Caranfil,Luisa Bertin,Fabiana Zingone
Cristina Caranfil
Purpose of review: Traditional approaches to irritable bowel syndrome with diarrhea (IBS-D) relied on extensive exclusionary testing and empiric symptom management. Recent advances in understanding neuroimmune pathophysio...
David N Assis
David N Assis
Yael Baharad,Tal Engel,Shomron Ben-Horin
Yael Baharad
Purpose of review: This review highlights the emerging role of dietary interventions for Crohn's disease (CD). Recent findings: An over...
Mechanistic insights into pancreatic duct pressure: from basic physiology to translational implications [0.03%]
胰管压力的机制研究：从基础生理学到转化意义
Jianing Li,Li Wen,Aiming Yang
Jianing Li
Purpose of review: This review summarizes recent advances in pancreatic ductal hypertension (PDH), emphasizing its pathophysiological mechanisms, clinical relevance across pancreatic diseases, and progress in noninvasive ...
Management of autoimmune hepatitis-related decompensated cirrhosis: current evidence and clinical decision-making [0.03%]
自身免疫性肝炎相关失代偿期肝硬化的管理：现有证据和临床决策
Pinelopi Arvaniti,Maria-Carlota Londoño
Pinelopi Arvaniti
Purpose of review: Autoimmune hepatitis (AIH) presenting with decompensated cirrhosis poses a major therapeutic dilemma for clinicians. Although the prompt initiation of immunosuppression (IS) can reverse disease activity...
Anna Palmiotti,Anna Bertolini,Romina Fiorotto
Anna Palmiotti
Purpose of review: Cystic fibrosis liver disease (CFLD) is a significant nonpulmonary complication of cystic fibrosis, affecting approximately 5-10% of patients. It encompasses a spectrum of hepatic abnormalities ranging ...
Clinical management and outcomes of hepatobiliary disease in the cystic fibrosis transmembrane conductance regulator modulator era [0.03%]
囊性纤维化跨膜传导调节剂时代肝胆病的临床管理及转归
Carolena Trocchia,Lauren Lazar,Zachary M Sellers
Carolena Trocchia
Purpose of review: Multiple cystic fibrosis transmembrane conductance regulator (CFTR) modulators are approved for the treatment of cystic fibrosis (CF) and show significant improvement in lung function, BMI, quality of l...